Carregando...
Natalizumab in Multiple Sclerosis: Long-Term Management
Natalizumab is a monoclonal antibody highly effective in the treatment of relapsing remitting multiple sclerosis (RRMS) patients. Despite its effectiveness, there are growing concerns regarding the risk of progressive multifocal leukoencephalopathy (PML), a brain infection caused by John Cunningham...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5454853/ https://ncbi.nlm.nih.gov/pubmed/28468254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18050940 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|